iTRAQ plasma proteomics analysis for candidate biomarkers of type 2 incipient diabetic nephropathy

Background Diabetic nephropathy is the most frequent cause of end-stage renal disease worldwide. Identification of biomarkers for diabetic nephropathy for early diagnosis may be the key to avoiding damage from this condition.